Envoy Medical (COCH) CEO Brent Lucas Buys 1,000,000 Shares
Brent Lucas, CEO of COCH, acquired 1 million shares in a recent transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Brent Lucas, Chief Executive Officer at Envoy Medical, Inc. ($COCH), bought 1,000,000 shares on June 19, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $COCH is up 6.3% after 1 week, up 6.3% after 1 month and up 6.3% to date (from the $0.63 close on Jun 18, 2026).
COCH
Envoy Medical, Inc.
Key Points
- Brent Lucas, CEO of COCH, bought 1 million shares on June 19, 2026, at an undisclosed price.
- Shares of COCH traded near $0.66 on Wednesday, with recent insider buying activity noted.
- Nantahala Capital Management and Bleichroeder LP also opened new positions in COCH.
Get $COCH trade alerts by text
We text you when insiders, Congress or big funds trade $COCH. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Envoy Medical, Inc. alert may contain errors. Disclosures
Brent Lucas, the Chief Executive Officer of COCH, made a significant move by purchasing 1 million shares of the company on June 19, 2026. This transaction was not part of a pre-planned trading scheme, and the shares were acquired at an undisclosed price.
Insider Buying and Selling at Envoy Medical, Inc.
Brent Lucas has been actively buying shares of COCH. On June 19, 2026, he purchased 1 million shares, adding to his previous acquisition of 32,856 shares at $0.60 each on May 29, 2026. Other notable insider purchases include Chas McKhann's acquisition of 100,000 shares on April 15, 2026, and Glen Taylor's purchase of 11.25 million shares on February 12, 2026.
Other Institutional Activity in COCH
Several institutional investors have recently opened new positions in COCH. Nantahala Capital Management acquired 7.65 million shares worth about $5.09 million. Bleichroeder LP also entered the scene with 6.25 million shares valued at approximately $4.16 million. Vanguard Capital Management LLC joined with 881,672 shares, worth around $586,312. DSG Capital Advisors, LLC added 625,000 shares to its portfolio, valued at $415,688. Notably, Geode Capital Management, LLC increased its holdings by 423,473 shares, bringing its total to 521,824 shares valued at $347,083, marking a 430.6% increase.
Analysts Set New Price Targets
On March 31, 2026, HC Wainwright & Co. initiated coverage on COCH with a 'buy' rating and set a price target of $2.50. Meanwhile, Ascendiant Capital has consistently maintained a 'buy' rating with varying price targets, the latest being $9.50 on May 27, 2025. Lake Street also maintained a 'buy' rating with a $6.00 target on July 25, 2024.
Bottom Line
COCH's CEO, Brent Lucas, has shown strong confidence in the company by purchasing a substantial number of shares. This insider activity, along with new positions from institutional investors, suggests growing interest in the company. As always, it's important to remember that insider transactions and institutional filings are backward-looking and may not reflect current positions.
Related Filing Alerts
Source: Brent Lucas's Form 4 filing on $COCH (Jun 19, 2026). Find the original filing: COCH Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts